Personalis, Inc. (PSNL): Capital Expenditures
$4.50M
Year ended 2025-12-31
$8.68M
Trailing 12 months to 2026-06-30
-55.1%
3-year compound annual growth
+6.8%
5-year compound annual growth
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $4.50M | +181.0% | 2026-02-26, From 2025-01-01 |
| 2024-12-31 | $1.60M | -85.3% | 2026-02-26, From 2024-01-01 |
| 2023-12-31 | $10.91M | -78.1% | 2025-02-27, From 2023-01-01 |
| 2022-12-31 | $49.90M | +350.2% | 2024-02-28, From 2022-01-01 |
| 2021-12-31 | $11.08M | +241.4% | 2024-02-28, From 2021-01-01 |
| 2020-12-31 | $3.25M | -61.3% | 2023-02-23, From 2020-01-01 |
| 2019-12-31 | $8.38M | +6.7% | 2022-02-24, From 2019-01-01 |
| 2018-12-31 | $7.85M | +52.2% | 2021-02-25, From 2018-01-01 |
| 2017-12-31 | $5.16M | n/a | 2020-03-25, From 2017-01-01 |
Capital Expenditures at similar companies
| Company | Year ended | Capital Expenditures | Change YoY |
|---|---|---|---|
| Personalis, Inc. (PSNL) | 2025-12-31 | $4.50M | +181.0% |
| Exagen Inc. (XGN) | 2025-12-31 | $641.0K | +24.5% |
| Biodesix Inc (BDSX) | 2025-12-31 | $259.0K | -92.0% |
| GRAIL, Inc. (GRAL) | 2025-12-31 | $909.0K | -82.5% |
| CapForce Inc. (CFOR) | 2025-12-31 | $50.0K | n/a |
| American Shared Hospital Services (AMS) | 2025-12-31 | $7.63M | -3.8% |
| BillionToOne, Inc. (BLLN) | 2025-12-31 | $8.88M | +64.4% |
| Fulgent Genetics, Inc. (FLGT) | 2025-12-31 | $22.57M | -44.0% |
| Castle Biosciences Inc (CSTL) | 2025-12-31 | $36.02M | +27.2% |
Compare PSNL, XGN, BDSX, GRAL side by side · Screen every company in Services-Medical Laboratories ↗